Sage Therapeutics Inc (SAGE)
6.05
-0.03
(-0.49%)
USD |
NASDAQ |
Nov 01, 16:00
6.047
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Enterprise Value: -199.06M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | -199.06M |
| October 31, 2024 | -197.22M |
| October 30, 2024 | -175.20M |
| October 29, 2024 | -50.40M |
| October 28, 2024 | -46.73M |
| October 25, 2024 | -79.16M |
| October 24, 2024 | -88.94M |
| October 23, 2024 | -101.18M |
| October 22, 2024 | -101.18M |
| October 21, 2024 | -92.61M |
| October 18, 2024 | -106.07M |
| October 17, 2024 | -128.09M |
| October 16, 2024 | -124.42M |
| October 15, 2024 | -149.51M |
| October 14, 2024 | -152.56M |
| October 11, 2024 | -166.02M |
| October 10, 2024 | -179.48M |
| October 09, 2024 | -172.14M |
| October 08, 2024 | -175.81M |
| October 07, 2024 | -158.07M |
| October 04, 2024 | -162.96M |
| October 03, 2024 | -141.55M |
| October 02, 2024 | -142.16M |
| October 01, 2024 | -143.39M |
| September 30, 2024 | -127.48M |
| Date | Value |
|---|---|
| September 27, 2024 | -201.74M |
| September 26, 2024 | -209.06M |
| September 25, 2024 | -218.22M |
| September 24, 2024 | -200.51M |
| September 23, 2024 | -205.40M |
| September 20, 2024 | -188.92M |
| September 19, 2024 | -164.49M |
| September 18, 2024 | -183.42M |
| September 17, 2024 | -187.69M |
| September 16, 2024 | -184.64M |
| September 13, 2024 | -168.77M |
| September 12, 2024 | -197.46M |
| September 11, 2024 | -189.53M |
| September 10, 2024 | -198.07M |
| September 09, 2024 | -192.58M |
| September 06, 2024 | -188.92M |
| September 05, 2024 | -180.37M |
| September 04, 2024 | -158.39M |
| September 03, 2024 | -163.88M |
| August 30, 2024 | -132.14M |
| August 29, 2024 | -152.90M |
| August 28, 2024 | -164.49M |
| August 27, 2024 | -151.67M |
| August 26, 2024 | -141.30M |
| August 23, 2024 | -133.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-218.22M
Minimum
Sep 25 2024
6.898B
Maximum
Nov 29 2019
1.219B
Average
842.81M
Median
Sep 01 2021
Enterprise Value Benchmarks
| Outset Medical Inc | 33.92M |
| Biogen Inc | 29.92B |
| Johnson & Johnson | 400.99B |
| Lifecore Biomedical Inc | 338.76M |
| Organon & Co | 12.64B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -93.55M |
| Revenue (Quarterly) | 11.87M |
| Total Expenses (Quarterly) | 113.07M |
| EPS Diluted (Quarterly) | -1.53 |
| Gross Profit Margin (Quarterly) | 55.54% |
| Profit Margin (Quarterly) | -788.1% |
| Earnings Yield | -92.07% |
| Normalized Earnings Yield | -92.12 |